CHEK1 and neoplasm: The relatively small proportion of tumours with high levels of endogenous replication stress can be targeted by CHK1 inhibitors (CHK1i) as a single agent to selectively destroy these tumours (Brooks et al., 2013; Oo et al., 2018; Sakurikar et al., 2016).